Skip to main content

NEPHROS INC (NEPH) Stock Forecast 2025 - AI Price Prediction & Analysis


NEPHROS INC (NEPH) AI Stock Price Forecast & Investment Analysis

NEPHROS INC Stock Price Chart and Technical Analysis

Loading NEPHROS INC interactive price chart and technical analysis...

NEPHROS INC (NEPH) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

NEPHROS INC (Stock Symbol: NEPH) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry. The organization employs approximately 56 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $16 million generating a -56.2% net profit margin .

Market Capitalization: $39 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -48.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for NEPHROS INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

NEPHROS INC strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . . The company maintains a healthy 52.6% gross margin, indicating strong pricing power and operational efficiency.

NEPHROS INC (NEPH) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for NEPHROS INC stock analysis.

Loading NEPHROS INC comprehensive fundamental analysis and insider trading data...

Deep dive into NEPHROS INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if NEPHROS INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For NEPHROS INC: With a P/E ratio of -20.28, the market sees the stock as potentially undervalued.

P/E Ratio -20.28x
P/B Ratio 2.02x
Market Cap $39M
EPS $0.12
Book Value/Share $0.79
Revenue/Share $0.09
FCF/Share $-0.61
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently NEPHROS INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NEPHROS INC: An ROE of -48.9% indicates room for improvement in shareholder value creation.

ROE -48.9%
ROA -33.1%
ROIC -43.8%
Gross Margin 52.6%
Operating Margin -53.5%
Net Margin -56.2%
EBT Margin -53.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess NEPHROS INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For NEPHROS INC: A current ratio of 6.67 indicates strong liquidity.

Current Ratio 6.67x
Quick Ratio 3.84x
D/E Ratio 0.04x
Financial Leverage 1.53x
Interest Coverage -150.3x
Working Capital $14M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal NEPHROS INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For NEPHROS INC: Free cash flow of $-3M indicates cash challenges that need attention.

Operating Cash Flow $-3M
Free Cash Flow $-3M
FCF/Sales -32.5%
CapEx/Sales 0.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively NEPHROS INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For NEPHROS INC: An asset turnover of 0.58x suggests room for improvement in asset utilization.

Asset Turnover 0.58x
Receivables Turnover 6.6x
Inventory Turnover 1.0x
Fixed Assets Turnover 8.5x
Days Sales Outstanding 56 days
Days Inventory 365 days
Payables Period 54 days
Cash Conversion Cycle 367 days
Understanding Financial Statement Data

What these metrics mean: Key figures from NEPHROS INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For NEPHROS INC: With annual revenue of $16M, NEPHROS INC represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $16M
R&D Expense $1M
SG&A Expense $82M
Cost of Goods Sold $5M
Balance Sheet Highlights ($ Millions)
Total Current Assets $75M
Cash & Short-term Investments $35M
Total Liabilities $17M
Short-term Debt $2M
Accounts Receivable $8M
Inventory $30M
Dividend & Shareholder Information
Shares Outstanding 11M
Growth Metrics (YoY)
EPS Growth -1.9%

Latest NEPHROS INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting NEPHROS INC (NEPH) stock price and investment outlook.

, source: Yahoo Finance

Get the latest Nephros, Inc. (NEPH) stock news and headlines to help you in your trading and investing decisions.

NEPHROS INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of NEPHROS INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast $20M x 2.3x
AEMD Unlock Forecast $3M -0.1x 0.7x
AFIB Unlock Forecast $0M 0.0x -0.4x
ALUR Unlock Forecast $17M -0.4x -0.3x
AMIX Unlock Forecast $4M x 0.5x
ANGO Unlock Forecast $387M -1.4x 2.1x
ANIK Unlock Forecast $139M -4.3x 0.9x
AORT Unlock Forecast $1950M -198.2x 4.6x
APYX Unlock Forecast $81M -3.5x 11.2x
ARAY Unlock Forecast $138M -9.9x 2.8x
ATEC Unlock Forecast $2362M -7.4x 99.4x
ATRC Unlock Forecast $1855M -39.6x 4.0x
AVGR Unlock Forecast $2M -1.3x 0.4x
AVHHL Unlock Forecast $22M x x
BAX Unlock Forecast $12644M -94.9x 1.7x
BBNX Unlock Forecast $825M x 2.7x
BDX Unlock Forecast $55712M 35.2x 2.2x
BEAT Unlock Forecast $37M -5.7x 9.0x
BEATW Unlock Forecast $15M x 3.2x
BJDX Unlock Forecast $2M -0.5x 0.4x
BLAC Unlock Forecast $12M x -2.1x
BLACR Unlock Forecast $1M x -0.2x
BLACU Unlock Forecast $14M x -2.4x
BLACW Unlock Forecast $0M x 0.0x
BSX Unlock Forecast $157543M 62.9x 7.0x
BTCY Unlock Forecast $10M -2.7x -0.1x
BVS Unlock Forecast $647M -18.3x 4.0x
CERS Unlock Forecast $235M -13.8x 4.2x
CLPT Unlock Forecast $304M -23.5x 15.4x
CODX Unlock Forecast $12M -0.7x 0.3x
CTCX Unlock Forecast $5M -0.2x -1.2x
CTCXW Unlock Forecast $1M x -0.2x
CTSO Unlock Forecast $64M -1.8x 4.4x
CVRX Unlock Forecast $204M -5.5x 3.5x
DCTH Unlock Forecast $444M 198.7x 4.2x
DHAI Unlock Forecast $10M x -0.3x
DHAIW Unlock Forecast $1M x 0.0x
DRIO Unlock Forecast $30M 0.6x 0.4x
DRTS Unlock Forecast $269M x 3.1x
DXCM Unlock Forecast $30724M 53.8x 11.9x
EBRCZ Unlock Forecast $246M x 5.0x
EMBC Unlock Forecast $572M 15.8x -0.8x
FEMY Unlock Forecast $19M -1.4x 12.3x
FNA Unlock Forecast $1098M -15.4x 8.4x
FOFA Unlock Forecast $8M x 13.6x
GCTK Unlock Forecast $2M 0.9x -0.5x
GIPL Unlock Forecast $5M x 27.9x
GKOS Unlock Forecast $5486M -46.3x 7.2x
GMED Unlock Forecast $8464M 23.7x 2.0x
GUTS Unlock Forecast $88M x 13.8x
HAE Unlock Forecast $3541M 26.1x 4.3x
HRGN Unlock Forecast $26M x 34.6x
IART Unlock Forecast $1159M 200.2x 1.1x
ICAD Unlock Forecast $106M -3.1x 3.5x
ICCM Unlock Forecast $52M x 17.9x
ICU Unlock Forecast $8M -1.1x 13.3x
ICUCW Unlock Forecast $0M x -0.1x
ICUI Unlock Forecast $3248M -49.8x 1.6x
IDXG Unlock Forecast $24M 4.7x -0.9x
IINN Unlock Forecast $28M x 6.5x
IINNW Unlock Forecast $10M x 2.4x
INBS Unlock Forecast $10M -0.3x 3.4x
INFU Unlock Forecast $207M 40.8x 3.8x
INSP Unlock Forecast $2774M 52.2x 4.1x
IRMD Unlock Forecast $929M 45.0x 9.9x
IRTC Unlock Forecast $5457M -20.2x 52.7x
IVF Unlock Forecast $1M x 0.3x
KIDS Unlock Forecast $472M -20.7x 1.3x
KMTS Unlock Forecast $829M x x
KRMD Unlock Forecast $203M -19.8x 12.3x
LMAT Unlock Forecast $0M 58.7x 0.0x
LNSR Unlock Forecast $62M -6.7x -7.0x
LUCD Unlock Forecast $112M -0.6x 14.3x
LUNG Unlock Forecast $69M -4.3x 1.0x
LYRA Unlock Forecast $524M -0.1x 135.2x
MBOT Unlock Forecast $92M -1.3x 3.2x
MCAG Unlock Forecast $22M x -9.6x
MCAGU Unlock Forecast $21M x -9.9x
MDAI Unlock Forecast $69M -1.3x -42.3x
MDAIW Unlock Forecast $9M x -2.1x
MDNC Unlock Forecast $59M 26.8x 13.4x
MDXG Unlock Forecast $1058M 32.9x 4.9x
MGRM Unlock Forecast $196M -10.7x 22.7x
MHUA Unlock Forecast $13M x 0.1x
MMM Unlock Forecast $85843M 21.8x 20.0x
MMSI Unlock Forecast $5518M 46.3x 3.7x
MODD Unlock Forecast $38M -2.1x 2.2x
NARI Unlock Forecast $4677M -51.9x 10.8x
NAYA Unlock Forecast $2M -0.3x 0.2x
NEPH Unlock Forecast $39M -20.3x 2.0x
NMTC Unlock Forecast $39M -1.7x 4.8x
NPCE Unlock Forecast $297M -10.4x 15.3x
NSPR Unlock Forecast $120M -4.3x 5.9x
NURO Unlock Forecast $9M -0.5x 0.7x
NVAC Unlock Forecast $69M 84.3x -13.6x
NVACR Unlock Forecast $1M x -0.1x
NVACW Unlock Forecast $0M x 0.0x
NVCR Unlock Forecast $1390M -20.8x 4.0x
NVNO Unlock Forecast $87M -2.0x 2.3x
NVRO Unlock Forecast $221M -2.1x 1.0x
NXGL Unlock Forecast $20M -6.8x 4.2x
NXGLW Unlock Forecast $3M x 0.7x
OBIO Unlock Forecast $118M -3.4x 2.0x
OFIX Unlock Forecast $573M -5.8x 1.3x
OSRH Unlock Forecast $17M x 0.2x
OSUR Unlock Forecast $224M 17.1x 0.6x
PAVM Unlock Forecast $22M 0.3x 0.6x
PAVMZ Unlock Forecast $0M x 0.0x
PDEX Unlock Forecast $155M 16.5x 4.4x
PEN Unlock Forecast $10691M 72.4x 8.3x
PETV Unlock Forecast $18M -1.4x 12.0x
PLSE Unlock Forecast $1016M -2.6x 8.6x
PODD Unlock Forecast $24009M 101.7x 16.4x
PRCT Unlock Forecast $2244M -45.4x 5.8x
PROF Unlock Forecast $142M x 3.6x
PSTV Unlock Forecast $12M -0.3x -0.5x
PYPD Unlock Forecast $54M x 2.6x
RCEL Unlock Forecast $129M -5.0x -29.9x
RDGL Unlock Forecast $47M x 17.5x
RMD Unlock Forecast $40446M 28.9x 6.8x
RSMDF Unlock Forecast $2450M 1.8x 0.4x
RTGN Unlock Forecast $66M x x
RVP Unlock Forecast $25M -0.9x 0.3x
SGHT Unlock Forecast $220M -3.7x 3.1x
SIBN Unlock Forecast $706M -14.3x 4.2x
SINT Unlock Forecast $7M -0.5x 1.1x
SKIN Unlock Forecast $311M -1.8x 4.2x
SNOA Unlock Forecast $8M -5.6x 2.1x
SNWV Unlock Forecast $374M x -19.4x
SOLV Unlock Forecast $12791M 33.7x 3.5x
SRDX Unlock Forecast $432M -79.3x 3.9x
SRTS Unlock Forecast $51M 31.6x 1.0x
SSII Unlock Forecast $1535M x 37.9x
SSKN Unlock Forecast $7M -8.0x 23.7x
STIM Unlock Forecast $261M -1.0x 9.6x
STME Unlock Forecast $12M x x
STSS Unlock Forecast $8M -2.5x 0.5x
STSSW Unlock Forecast $0M x 0.0x
SYK Unlock Forecast $140684M 42.0x 12.0x
TCMD Unlock Forecast $313M 20.7x 1.6x
TELA Unlock Forecast $80M -1.8x 8.7x
TFX Unlock Forecast $5704M 29.7x 1.3x
TLSI Unlock Forecast $191M -3.6x -5.6x
TLSIW Unlock Forecast $66M x -1.9x
TMCI Unlock Forecast $628M -7.5x 6.0x
TNDM Unlock Forecast $845M -17.1x 6.3x
TNON Unlock Forecast $11M -0.3x 1.7x
TNONW Unlock Forecast $0M x 0.0x
TTOO Unlock Forecast $4M 0.0x -0.3x
UFPT Unlock Forecast $1757M 44.7x 4.9x
USAQ Unlock Forecast $2M x x
UTMD Unlock Forecast $200M 15.9x 1.7x
VERO Unlock Forecast $5M 0.0x 2.3x
VTAK Unlock Forecast $3M 0.0x 0.3x
VVOS Unlock Forecast $21M -0.5x 2.8x
WST Unlock Forecast $17978M 36.9x 6.1x
XAIR Unlock Forecast $303M -0.3x 22.3x
XTNT Unlock Forecast $95M -478.8x 2.0x

Frequently Asked Questions - NEPHROS INC Stock Forecast

How accurate are NEPHROS INC stock predictions?

Our AI model demonstrates 47% historical accuracy for NEPH predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence NEPHROS INC stock price forecasts?

Our analysis considers NEPHROS INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is NEPHROS INC a good investment in 2025?

Based on our AI analysis, NEPHROS INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are NEPHROS INC forecasts updated?

NEPHROS INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced NEPHROS INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for NEPHROS INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...